About ABEONA THERAPEUTICS INC.
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. The company's ZEVASKYN® (prademagene zamikeracel) was approved in April 2025 and is manufactured at its fully integrated cGMP facility in Cleveland, Ohio.
Is this your company?
Claim ABEONA THERAPEUTICS INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ABEONA THERAPEUTICS INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.